Compare GSK plc (GSK) vs Wheaton Precious Metals Corp (WPM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Wheaton Precious Metals Corp — how do they compare? GSK plc trades at $52.48 (market cap $101.34B), while Wheaton Precious Metals Corp trades at $105.09 (market cap $48.80B). The key difference: GSK plc is far larger — about 2.1× Wheaton Precious Metals Corp's market cap, and GSK plc pays the higher dividend (3.49%). Which is the better fit depends on your goals.
| GSK | WPM | |
|---|---|---|
Market Cap | $101.34B | $48.80B |
Sector | Health | Basic Materials |
52-Week High | $61.18 | $165.72 |
52-Week Low | $36.20 | $88.32 |
Enterprise Value | $121.95B | $46.65B |
Dividend Yield | 3.49% | 0.72% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK's stock trades at $51.25, down 1.99% on the day, with a bearish technical signal from moving averages. Fundamentally, the company shows strong profitability with a 17.78% net margin and 36.42% ROE, supported by a consistent earnings beat history. Recent positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline progress. Valuation appears reasonable with a P/E of 13.71 and EV/EBITDA of 9.16.
The outlook balances a solid core business and promising oncology pipeline against a mixed analyst consensus and near-term cash flow pressures. Key opportunities lie in execution of new drug launches and the upcoming CEO strategy update, while risks include clinical trial setbacks, competitive pressures, and integration of potential acquisitions like Nuvalent.
Wheaton Precious Metals (WPM) trades at $108.49, up 0.61% on the day, amid a bearish technical signal but strong fundamental performance. The company reported record operating cash flow of $1.9 billion in 2025, with revenue surging to $2.31 billion and net income reaching $1.47 billion. Recent quarterly earnings have consistently beaten expectations, and analyst consensus remains strongly bullish with an 80% buy rating and a $161.75 price target, suggesting significant upside from current levels.
The outlook for WPM is positive, driven by robust cash flow generation, production growth, and favorable precious metal exposure. Key risks include sensitivity to commodity price volatility and macroeconomic pressures. With a high valuation (P/E 27.43) but strong profitability (ROE 21.54%), the stock presents a growth opportunity tempered by market cyclicality.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Wheaton Precious Metals Corp
Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.
Read more on WPM →
